Dopamine and serotonin neurotransmitter systems

The dopamine and serotonin neurotransmitter systems are two primary monoaminergic pathways in the central nervous system that work in a complex, often reciprocal, relationship to regulate behavior and physiology. Dopamine is centrally involved in the brain's reward circuitry, motor coordination, and executive functions, while serotonin plays a dominant role in mood stabilization, emotional processing, and homeostatic functions like sleep and appetite [2, 7]. These systems are highly integrated; for instance, serotonergic projections from the raphe nuclei modulate dopaminergic activity in the striatum and prefrontal cortex, acting as a regulatory 'brake' or 'accelerator' depending on the receptor subtype involved [3, 9]. Dysregulation of this delicate balance is implicated in a wide range of neuropsychiatric conditions, including the positive and negative symptoms of schizophrenia, the affective shifts in bipolar disorder, and the motor deficits of Parkinson's disease [8, 10]. Modern pharmacotherapy frequently targets both systems simultaneously, as seen with atypical antipsychotics (serotonin-dopamine activity modulators) which aim to stabilize dopamine signaling while utilizing serotonin receptor antagonism to mitigate side effects and improve cognitive outcomes [4, 6].

Other names

Dopaminergic and serotonergic systemsMonoaminergic neurotransmitter systemsDA/5-HT systemsDopamine-serotonin system

Modulation of synaptic neurotransmission through the agonism or antagonism of specific dopamine (D1-D5) and serotonin (5-HT1-7) receptors, as well as the inhibition of reuptake transporters (DAT and SERT) and metabolic enzymes (MAO and COMT).